Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 8081 | 2.015 |
09:34 ET | 500 | 2.0001 |
09:36 ET | 990 | 2.0199 |
09:38 ET | 300 | 2.025 |
09:41 ET | 2190 | 2.0232 |
09:43 ET | 100 | 2.02 |
09:45 ET | 2700 | 2.04 |
09:50 ET | 2463 | 2.0499 |
09:52 ET | 5250 | 2.045 |
09:54 ET | 1000 | 2.0499 |
09:56 ET | 1200 | 2.045 |
09:57 ET | 10119 | 2.07 |
09:59 ET | 5960 | 2.0607 |
10:01 ET | 19537 | 2.09 |
10:03 ET | 9700 | 2.1099 |
10:06 ET | 20939 | 2.1086 |
10:08 ET | 23411 | 2.1 |
10:10 ET | 12610 | 2.0999 |
10:12 ET | 28751 | 2.0394 |
10:14 ET | 425 | 2.035 |
10:15 ET | 2200 | 2.0499 |
10:17 ET | 808 | 2.0599 |
10:19 ET | 120 | 2.0598 |
10:21 ET | 2300 | 2.0409 |
10:24 ET | 6000 | 2.05 |
10:26 ET | 650 | 2.0581 |
10:28 ET | 2900 | 2.04 |
10:30 ET | 1050 | 2.05 |
10:32 ET | 450 | 2.0452 |
10:35 ET | 1400 | 2.0405 |
10:37 ET | 1880 | 2.05 |
10:39 ET | 100 | 2.05 |
10:42 ET | 200 | 2.045 |
10:44 ET | 600 | 2.05 |
10:46 ET | 21038 | 2.0799 |
10:48 ET | 5048 | 2.0775 |
10:50 ET | 1375 | 2.06 |
10:51 ET | 1590 | 2.06 |
10:55 ET | 500 | 2.0599 |
10:57 ET | 1500 | 2.059 |
11:02 ET | 500 | 2.0599 |
11:04 ET | 1800 | 2.055 |
11:08 ET | 1000 | 2.06 |
11:13 ET | 750 | 2.0591 |
11:15 ET | 250 | 2.0599 |
11:20 ET | 1656 | 2.0599 |
11:22 ET | 1200 | 2.055 |
11:24 ET | 500 | 2.0501 |
11:26 ET | 4650 | 2.0501 |
11:31 ET | 400 | 2.05 |
11:36 ET | 1723 | 2.0501 |
11:38 ET | 23635 | 2.055 |
11:40 ET | 6814 | 2.078 |
11:44 ET | 700 | 2.0799 |
11:45 ET | 1000 | 2.075 |
11:47 ET | 3000 | 2.0701 |
11:49 ET | 461 | 2.07 |
11:51 ET | 441 | 2.07 |
11:54 ET | 100 | 2.0663 |
11:56 ET | 1000 | 2.051 |
11:58 ET | 1150 | 2.0699 |
12:03 ET | 19238 | 2.06 |
12:07 ET | 1000 | 2.0601 |
12:14 ET | 2000 | 2.0697 |
12:16 ET | 2560 | 2.06 |
12:18 ET | 200 | 2.065 |
12:20 ET | 100 | 2.065 |
12:32 ET | 125 | 2.0677 |
12:38 ET | 600 | 2.065 |
12:39 ET | 8157 | 2.075 |
12:41 ET | 5015 | 2.07 |
12:45 ET | 2126 | 2.075 |
12:48 ET | 100 | 2.07 |
12:50 ET | 200 | 2.0713 |
12:56 ET | 250 | 2.0799 |
01:03 ET | 1035 | 2.075 |
01:06 ET | 300 | 2.075 |
01:14 ET | 520 | 2.08 |
01:19 ET | 1200 | 2.08 |
01:21 ET | 100 | 2.07 |
01:26 ET | 2340 | 2.0799 |
01:30 ET | 611 | 2.065 |
01:32 ET | 6314 | 2.06 |
01:33 ET | 200 | 2.0601 |
01:48 ET | 2589 | 2.0701 |
01:50 ET | 10910 | 2.065 |
01:57 ET | 15274 | 2.06 |
02:00 ET | 1200 | 2.0662 |
02:06 ET | 330 | 2.0601 |
02:08 ET | 3400 | 2.06 |
02:09 ET | 2950 | 2.06 |
02:13 ET | 800 | 2.06 |
02:24 ET | 300 | 2.0608 |
02:26 ET | 300 | 2.065 |
02:31 ET | 202 | 2.0601 |
02:33 ET | 12080 | 2.07 |
02:38 ET | 900 | 2.07 |
02:40 ET | 1600 | 2.06 |
02:42 ET | 3380 | 2.06 |
02:44 ET | 1100 | 2.06 |
02:45 ET | 700 | 2.0686 |
02:47 ET | 200 | 2.06 |
02:54 ET | 3000 | 2.05 |
02:56 ET | 500 | 2.05 |
02:58 ET | 550 | 2.05 |
03:03 ET | 360 | 2.05 |
03:05 ET | 800 | 2.05 |
03:07 ET | 1400 | 2.054 |
03:09 ET | 1000 | 2.06 |
03:12 ET | 5734 | 2.06 |
03:14 ET | 700 | 2.06 |
03:20 ET | 100 | 2.05 |
03:21 ET | 200 | 2.05 |
03:32 ET | 1000 | 2.0585 |
03:34 ET | 200 | 2.05 |
03:39 ET | 2520 | 2.055 |
03:41 ET | 4331 | 2.05 |
03:43 ET | 2444 | 2.055 |
03:45 ET | 300 | 2.055 |
03:48 ET | 200 | 2.055 |
03:50 ET | 100 | 2.05 |
03:52 ET | 100 | 2.05 |
03:54 ET | 100 | 2.05 |
03:56 ET | 16293 | 2.06 |
03:57 ET | 4643 | 2.065 |
03:59 ET | 5670 | 2.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 130.9M | -2.8x | --- |
Longboard Pharmaceuticals Inc | 128.9M | -2.2x | --- |
Enzolytics Inc | 133.4M | -0.4x | --- |
Annexon Inc | 128.3M | -1.2x | --- |
Design Therapeutics Inc | 134.4M | -1.8x | --- |
Trevi Therapeutics Inc | 135.4M | -6.2x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $130.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 63.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-0.73 |
Book Value | $0.83 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.